Cardiac Imaging In The VALOR-HCM Trial Cardiac Consult: A Cleveland Clinic Podcast For Healthcare Professionals podcast

Inhalt bereitgestellt von Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals »
Cardiac Imaging in the VALOR-HCM Trial

4d ago 31:28

MP3•Episode-Home

Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM). An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonographers and imagers.
Milind Desai, MD, MBA speaks with Jeanne Drinko, Amy Kanta and Anne Campbell about the importance of cardiac imaging.
Learn more about C5 Research at Cleveland Clinic.
https://my.clevelandclinic.org/research/c5research
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

298 Episoden

#Fitness #Cardiac Consult: For Healthcare Professionals #Cleveland Clinic #Vascular Institute #Cleveland Clinic Heart #Health Industry #Health and Well-Being #Health Care